CSF3 and acute myeloid leukemia: Multivariate Cox regression with chemotherapy dose groups (LDC/G-CSF and SDC) and the AML risk group (low, intermediate and high) as covariates (Supplementary Table S1) showed no significant association of chemotherapy dose with OS (hazard ratio (HR) = 0.955, P = 0.91) or EFS (HR = 1.052; P = 0.885).